Grant: Discovery Launch Supplement
University of Toronto
$12,500.00
Understanding the affinity based selection of germinal center B cells towards plasma cells
FY 2024-25
Summary
Antibodies (Abs) that neutralize pathogens are the ultimate goal of B cell vaccines. Upon exposure to foreign substances, B cells can bind to these antigens (Ags) with their Ab-like B cell receptors (BCRs), initiating a series of response mechanisms. Unique to B cells, they can undergo affinity maturation by forming germinal centers (GCs), within which B cells improve the binding capacity of their BCR to the Ag during an immune response. This is a critical prerequisite for GC B cells prior to differentiating into plasma cells (PCs) that can secrete their improved BCRs as high affinity soluble Abs that bind pathogens. Thus, a fundamental metric to gauge the effectiveness of humoral immunity should be to understand how BCR affinities in the GC are manifested amongst the Abs secreted by the PC compartment. Such an analysis would provide a powerful tool to orthogonally measure vaccine efficacy beyond current approaches that evaluate Ag specific Ab levels in a coarse grain manner without providing any in-depth assessments. Upon successful completion of this platform, we seek to examine clinical samples and query if disparate vaccine responses exist between different races, sex, and age amongst our population.
To achieve our proposed measure, quantitative tools that characterize the biochemical properties of BCRs are required. Currently, the state of the art approach relies on single cell sequencing of GC B cells for their BCRs followed by their recombinant expression as Abs and subsequent biochemical analyses. This process is lengthy and limiting especially due to resources needed to recombinantly produce each individual Ab. The main goal of my research program is to overcome these bottlenecks by directly measuring BCR affinities from cell surfaces without the need for sequencing and recombinant expression. In Aim 1, we will use fluorescence resonance energy transfer (FRET) based approaches to detect Ag-BCR interactions by labeling BCR with donor dyes while introducing Ags conjugated with acceptor dyes. In Aim 2, we will translate the FRET based approach towards high throughput analysis by using equilibrium binding analysis and microfluidics technology. In Aim 3, we will discuss how this platform will be used to understand the impact of different vaccine constituents (i.e. different adjuvants and Ag formats) on the PC selection process amongst GC B cells. Within this aim, we will also evaluate if sex-based differences exist in PC selection by using our platform to analyze both male and female mice.
With this research program, we will provide a direct and quantifiable measure of the conversion of GC B cells with known affinities towards PCs. We expect this platform to significantly aid future vaccine designs through assessment of vaccine efficacy in both preclinical and clinical settings. Through collaborations with the broader research community within Canada, we will strive to accelerate domestic vaccine development efforts.
Program
Discovery Launch Supplement
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
DGECR-2024-00451
Name nom
Aung, Aereas
Department département
Institute of Biomedical Engineering
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
12500
Program id
DGECR
Program name en
Discovery Launch Supplement
Program name fr
Supplément Tremplin vers la découverte
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Understanding the affinity based selection of germinal center B cells towards plasma cells
Keywords
germinal center; affinity maturation; plasma cells; b cell receptor affinity measurement; microfluidics; single cell analysis
Application summary
Antibodies (Abs) that neutralize pathogens are the ultimate goal of B cell vaccines. Upon exposure to foreign substances, B cells can bind to these antigens (Ags) with their Ab-like B cell receptors (BCRs), initiating a series of response mechanisms. Unique to B cells, they can undergo affinity maturation by forming germinal centers (GCs), within which B cells improve the binding capacity of their BCR to the Ag during an immune response. This is a critical prerequisite for GC B cells prior to differentiating into plasma cells (PCs) that can secrete their improved BCRs as high affinity soluble Abs that bind pathogens. Thus, a fundamental metric to gauge the effectiveness of humoral immunity should be to understand how BCR affinities in the GC are manifested amongst the Abs secreted by the PC compartment. Such an analysis would provide a powerful tool to orthogonally measure vaccine efficacy beyond current approaches that evaluate Ag specific Ab levels in a coarse grain manner without providing any in-depth assessments. Upon successful completion of this platform, we seek to examine clinical samples and query if disparate vaccine responses exist between different races, sex, and age amongst our population.
To achieve our proposed measure, quantitative tools that characterize the biochemical properties of BCRs are required. Currently, the state of the art approach relies on single cell sequencing of GC B cells for their BCRs followed by their recombinant expression as Abs and subsequent biochemical analyses. This process is lengthy and limiting especially due to resources needed to recombinantly produce each individual Ab. The main goal of my research program is to overcome these bottlenecks by directly measuring BCR affinities from cell surfaces without the need for sequencing and recombinant expression. In Aim 1, we will use fluorescence resonance energy transfer (FRET) based approaches to detect Ag-BCR interactions by labeling BCR with donor dyes while introducing Ags conjugated with acceptor dyes. In Aim 2, we will translate the FRET based approach towards high throughput analysis by using equilibrium binding analysis and microfluidics technology. In Aim 3, we will discuss how this platform will be used to understand the impact of different vaccine constituents (i.e. different adjuvants and Ag formats) on the PC selection process amongst GC B cells. Within this aim, we will also evaluate if sex-based differences exist in PC selection by using our platform to analyze both male and female mice.
With this research program, we will provide a direct and quantifiable measure of the conversion of GC B cells with known affinities towards PCs. We expect this platform to significantly aid future vaccine designs through assessment of vaccine efficacy in both preclinical and clinical settings. Through collaborations with the broader research community within Canada, we will strive to accelerate domestic vaccine development efforts.